Executive Brief: Competitive Landscape and Strategic Developments in the Female Infertility Market
The Female Infertility Market was valued at USD 2.5 billion in 2024 and is projected to reach USD 5.0 billion by 2034, registering a CAGR of 7.2%. This growth trajectory is underpinned by several factors, including the rising prevalence of infertility among women, increasing awareness regarding fertility treatments, and advancements in reproductive technologies. According to the World Health...